AT340071B - Verfahren zur herstellung von neuen difluormethylen-substituierten prostaglandinderivaten - Google Patents

Verfahren zur herstellung von neuen difluormethylen-substituierten prostaglandinderivaten

Info

Publication number
AT340071B
AT340071B AT778173A AT778173A AT340071B AT 340071 B AT340071 B AT 340071B AT 778173 A AT778173 A AT 778173A AT 778173 A AT778173 A AT 778173A AT 340071 B AT340071 B AT 340071B
Authority
AT
Austria
Prior art keywords
difluoromethylene
prostaglandin derivatives
manufacturing new
substituted prostaglandin
substituted
Prior art date
Application number
AT778173A
Other languages
English (en)
Other versions
ATA778173A (de
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ATA778173A publication Critical patent/ATA778173A/de
Application granted granted Critical
Publication of AT340071B publication Critical patent/AT340071B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/17—Unsaturated ethers containing halogen
    • C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/516—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of nitrogen-containing compounds to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT778173A 1972-09-08 1973-09-07 Verfahren zur herstellung von neuen difluormethylen-substituierten prostaglandinderivaten AT340071B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28733372A 1972-09-08 1972-09-08
US379127A US3867423A (en) 1972-09-08 1973-07-13 Difluoromethylene substituted prostaglandin derivatives

Publications (2)

Publication Number Publication Date
ATA778173A ATA778173A (de) 1977-03-15
AT340071B true AT340071B (de) 1977-11-25

Family

ID=26964400

Family Applications (1)

Application Number Title Priority Date Filing Date
AT778173A AT340071B (de) 1972-09-08 1973-09-07 Verfahren zur herstellung von neuen difluormethylen-substituierten prostaglandinderivaten

Country Status (13)

Country Link
US (1) US3867423A (de)
JP (1) JPS4992055A (de)
AT (1) AT340071B (de)
CA (1) CA1041496A (de)
CH (4) CH596167A5 (de)
DE (1) DE2344740A1 (de)
ES (1) ES418575A1 (de)
FR (1) FR2198754B1 (de)
GB (1) GB1414881A (de)
HK (1) HK75276A (de)
IL (1) IL42995A (de)
MY (1) MY7700075A (de)
NL (1) NL7312390A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5120803U (de) * 1974-07-31 1976-02-16
US4001295A (en) * 1975-06-23 1977-01-04 Syntex (U.S.A.) Inc. 11,12-difluoromethylene substituted prostanoic and prost-5-cis-enoic acid derivatives
US4188329A (en) * 1975-09-08 1980-02-12 Abbott Laboratories Intermediates for the preparation of prostaglandins and prostaglandin analogs from a mold metabolite
EP0329184A3 (de) * 1988-02-19 1990-05-23 Neorx Corporation Antimere und antimere Konjugation

Also Published As

Publication number Publication date
IL42995A0 (en) 1973-11-28
JPS4992055A (de) 1974-09-03
AU5974773A (en) 1975-03-06
CH595342A5 (de) 1978-02-15
FR2198754A1 (de) 1974-04-05
FR2198754B1 (de) 1976-09-03
GB1414881A (en) 1975-11-19
ES418575A1 (es) 1977-05-01
IL42995A (en) 1978-03-10
NL7312390A (de) 1974-03-12
MY7700075A (en) 1977-12-31
US3867423A (en) 1975-02-18
CA1041496A (en) 1978-10-31
HK75276A (en) 1976-12-10
CH596167A5 (de) 1978-02-28
CH602626A5 (de) 1978-07-31
CH595343A5 (de) 1978-02-15
ATA778173A (de) 1977-03-15
DE2344740A1 (de) 1974-03-21

Similar Documents

Publication Publication Date Title
ATA569473A (de) Verfahren zur herstellung von neuen enolderivaten
AT347609B (de) Verfahren zur herstellung von neuen cyclopentanderivaten
ATA993573A (de) Verfahren zur herstellung von neuen cephalosporinathern
AT333269B (de) Verfahren zur herstellung von neuen aroylsubstituierten phenylessigsaurederivaten
AT325605B (de) Verfahren zur herstellung von neuen alpha-phenylindolderivaten
AT329068B (de) Verfahren zur herstellung von neuen chinoxalin-di -n- oxid-derivaten
AT335418B (de) Verfahren zur herstellung von neuen alkylthiocyclopentanderivaten
AT330955B (de) Verfahren zur herstellung von neuen beta-lactamen
AT339913B (de) Verfahren zur herstellung von neuen diazin-derivaten
AT340072B (de) Verfahren zur herstellung von neuen pregnansaure-derivaten
AT327407B (de) Verfahren zur herstellung von neuen benzomorphanderivaten
ATA778173A (de) Verfahren zur herstellung von neuen difluormethylen-substituierten prostaglandinderivaten
AT323148B (de) Verfahren zur herstellung von neuen 5-aroylfuranderivaten
AT331805B (de) Verfahren zur herstellung von neuen triazinobenzimidazolen
AT323189B (de) Verfahren zur herstellung von neuen lactamen
AT324328B (de) Verfahren zur herstellung von neuen tetrahydropyran- bzw. -thiopyranderivaten
AT326145B (de) Verfahren zur herstellung von neuen phosphonoureidoverbindungen
AT333740B (de) Verfahren zur herstellung von neuen indanderivaten
AT332542B (de) Verfahren zur herstellung von neuen 7-acylamido -1-x-1- dethiacephalosporinderivaten
AT331971B (de) Verfahren zur herstellung von neuen 3-monoestern von rosamicin
ATA210976A (de) Verfahren zur herstellung von neuen alkylthio- cyclopentanderivaten
ATA896873A (de) Verfahren zur herstellung von neuen benzazocinderivaten
AT333989B (de) Verfahren zur herstellung von neuen pregnansaure-derivaten
AT329533B (de) Verfahren zur herstellung von neuen cyclopentanalen
AT325048B (de) Verfahren zur herstellung von neuen dihydro - 2 - aminoisochinolinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee